Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit
Rhea-AI Summary
BiomX (NYSE American: PHGE) appointed Prof. Gabby Sarusi as Strategic Advisor on June 2, 2026. He will support expansion into defense, security, critical infrastructure, and first-response sectors, advising on technology evaluation and long-term growth strategy.
Prof. Sarusi brings senior defense-industry, academic, board, and entrepreneurial experience in advanced imaging and sensing systems.
Positive
- Appointment of Prof. Gabby Sarusi as Strategic Advisor to BiomX
- Advisor brings 17 years of senior leadership experience at Elbit Systems Electro-Optics
- Expertise in infrared detectors, SWIR imaging, terahertz sensing, and advanced sensing technologies
- Role focused on defense, security, critical infrastructure, and first-response market opportunities
- Experience on boards of Israel Aerospace Industries, SCD, Opgal, and Medigus
- Background in founding companies in AI, augmented reality, nanotechnology, and optical diagnostics
Negative
- None.
News Market Reaction – PHGE
In the Jun 2 session, PHGE declined 15.83%, reflecting a significant negative market reaction. Argus tracked a trough of -26.0% from its starting point during tracking. Our momentum scanner triggered 21 alerts that day, indicating elevated trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 01 | Product suite expansion | Positive | -17.5% | Expanded Zorronet autonomous C5ISR suite for secure on‑premise and hybrid use. |
| May 27 | Executive appointment | Positive | -4.3% | Appointed IDF Colonel (res.) Roy Timor‑Rousso as CBO to drive defense focus. |
| May 06 | Product launch | Positive | -3.5% | Zorronet launched secure mobile AI command‑and‑control app for field operators. |
| Apr 16 | Customer pilot & deal | Positive | -6.6% | Israel Railways pilot with 98% success and framework for AI detection stations. |
| Apr 13 | Defense acquisition | Positive | -9.0% | Agreement to acquire DFSL, pairing LADAR sensing with Zorronet AI platform. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Across the last five news events, largely strategic and operationally positive announcements were followed by negative 24-hour price reactions, suggesting a pattern of selling into news.
Over the past few months, BiomX has been pivoting from biopharma to defense and security, highlighted by the DFSL acquisition, Zorronet’s AI-powered rail pilot with a 98% success rate, and the launch of mobile AI command-and-control tools. Governance and leadership changes, including the appointment of a Chief Business Officer for defense operations, reinforced this strategic turn. However, each of these announcements, including the expanded Zorronet C5ISR suite on Jun 01 2026, was followed by negative price reactions, indicating persistent market skepticism toward the transition and financial backdrop as today’s advisor appointment continues that narrative.
Key Terms
swir imaging technical
terahertz sensing technical
nanophotonics technical
infrared detectors technical
thermal imaging systems technical
hyperspectral observation technical
augmented reality technical
quantum photonic devices technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Defense-industry veteran brings experience developing imaging, sensing, and intelligence systems for aerospace, defense, and homeland security
NETANYA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), today announced the appointment of Prof. Gabby Sarusi as Strategic Advisor to the Company. Prof. Sarusi will advise BiomX as the Company as the company expands its presence in the defense, security, critical infrastructure, and first-response sectors, and drawing on his experience spanning technology development, operational leadership, and long-term strategic planning. His advisory role is expected to support management in evaluating new opportunities and advancing the Company's long-term growth strategy.
Prof. Sarusi brings a combination of scientific, defense-industry, commercial, and board-level experience. He currently serves as Full Professor and Head of the Photonics and Electro-Optics Department at Ben-Gurion University of the Negev. His research focuses on infrared detectors, quantum photonic devices, nanophotonics, SWIR imaging, terahertz sensing, and other advanced sensing technologies.
Prior to his academic career, Prof. Sarusi spent 17 years at Elbit Systems Electro-Optics, known as Elop, where he held senior leadership roles including Vice President and Chief Scientist, Vice President and Head of the Space and Air Imagery Intelligence Division, and Director of Development for advanced thermal imaging systems. During his tenure, he was involved in the development and management of technologies related to satellite cameras, aerial imaging systems, hyperspectral observation, infrared detectors, and thermal imaging systems.
Prof. Sarusi also served on the boards of several defense and technology companies, including Israel Aerospace Industries, SCD, Opgal, and Medigus. In addition, he has co-founded several technology companies, including companies active in artificial intelligence, augmented reality, nanotechnology, and optical diagnostics.
“Prof. Sarusi has spent much of his career working at the point where technology meets operational need,” said Michael Oster, Chief Executive Officer of BiomX. “Prof. Sarusi's candidacy for the chairmanship of Israel Aerospace Industries in 2025, supported by Israeli Defense Minister Israel Katz, speaks to the reputation and credibility he has built throughout Israel's defense and technology communities. His experience spans both the technology itself and the requirements of the organizations that depend on it. We are pleased to welcome him as a strategic advisor and look forward to benefiting from his insight and vast experience. As BiomX continues building around technologies that identify, track, and respond to physical threats, I believe his perspective will significantly advance our ability to evaluate opportunities with greater technical discipline while ensuring our strategy remains connected to the realities of defense, security, and critical-infrastructure adoption.”
“The defense and security market is moving toward systems that can detect earlier, interpret faster, and support more coordinated action,” said Prof. Gabby Sarusi. “BiomX is building around areas where sensing, intelligence, and response come together. I look forward to advising the Company as it evaluates technologies that can improve operational clarity and help security organizations respond more effectively to emerging threats.”
Prof. Sarusi holds dual bachelor’s degrees with honors in Nuclear Engineering and Materials Engineering from Ben-Gurion University of the Negev, a master’s degree with honors and a Ph.D. in Electrical Engineering from Tel Aviv University, and an Executive MBA from Tel Aviv University’s Recanati School of Business. He completed postdoctoral research at AT&T Bell Labs in New Jersey and NASA Jet Propulsion Laboratory in California.
About
BiomX Inc. is a company focused on acquiring and further developing technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response sectors. The Company's portfolio is built around the growing need for earlier and more accurate threat detection, particularly as UAVs and other autonomous systems play a larger role in defense and homeland security.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements regarding BiomX’s strategic expansion in the defense, security, critical infrastructure, and first-response sectors; the expected benefits of Prof. Gabby Sarusi’s appointment as Strategic Advisor; the Company’s ability to evaluate, develop, acquire, integrate, commercialize, or deploy defense and security technologies; the Company’s ability to build and manage a portfolio of complementary defense and security businesses; and the potential benefits of technologies related to threat detection, operational awareness, sensing, intelligence, and response coordination.
These statements are based on current expectations, estimates, assumptions, and beliefs of BiomX management and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Such risks include, among others, BiomX’s ability to execute its strategic transition; the Company’s ability to identify, evaluate, acquire, integrate, develop, commercialize, and scale defense and security technologies; the ability to convert technical validations, supplier approvals, collaboration opportunities, or strategic initiatives into commercial deployments or revenue; BiomX’s going concern qualification in its recent financial statements; customer adoption; changes in cybersecurity, regulatory, procurement, export-control, and operational requirements; competition; technical, integration, performance, security, or deployment challenges; and other risks described in BiomX’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K, as supplemented by the Form 10-K/A filed with the SEC on April 30, 2026, Current Report on Form 8-K filed with the SEC on May 5, 2026, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings. BiomX undertakes no obligation to update or revise any forward-looking statements, except as required by law.
Contact
Yair Ohayon
Yairo@biomx.com
